Two Color Single Molecule Sequencing on GenoCare 1600 Platform to Facilitate Clinical Applications
Chen, F.; Liu, B.; Chen, M.; Jiang, Z.; Zhou, Z.; Wu, P.; Zhang, M.; Jin, H.; Li, L.; Lu, L.; Wang, Q.; Shang, H.; Xie, B.; Liu, L.; Lin, X.; Chen, W.; Xu, J.; Sun, R.; Wang, G.; Zheng, J.; Qi, J.; Yang, B.; Chen, D.; Zeng, L.; Li, G.; Li, Y.; Lv, H.; Zhao, N.; Zhou, B.; Wang, W.; Cai, J.; Liu, S.; Luo, W.; Zhang, J.; Zhang, Y.; Lu, Y.; Fan, J.; Dan, H.; He, X.; Liu, L.; Feng, Y.; Chen, J.; Huang, W.; Sun, L.; Yan, Q.
Show abstract
With the rapid development of precision medicine industry, DNA sequencing becomes increasingly important as a research and diagnosis tool. For clinical applications, medical professionals require a platform which is fast, easy to use, and presents clear information relevant to definitive diagnosis. We have developed a single molecule desktop sequencing platform, GenoCare 1600. Fast library preparation (without amplification) and simple instrument operation make it friendlier for clinical use. Here we presented sequencing data of E. coli sample from GenoCare 1600 with consensus accuracy reaches 99.99%. We also demonstrated sequencing of microbial mixtures and COVID-19 samples from throat swabs. Our data show accurate quantitation of microbial, sensitive identification of SARS-CoV-2 virus and detection of variants confirmed by Sanger sequencing.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.